The role of CD36 in cardiovascular disease
H Shu, Y Peng, W Hang, J Nie, N Zhou… - Cardiovascular …, 2022 - academic.oup.com
CD36, also known as the scavenger receptor B2, is a multifunctional receptor widely
expressed in various organs. CD36 plays a crucial role in the uptake of long-chain fatty …
expressed in various organs. CD36 plays a crucial role in the uptake of long-chain fatty …
Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
S Vučković, R Dinani, EE Nollet, DWD Kuster… - Stem cell research & …, 2022 - Springer
Background Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have
emerged as a powerful tool for disease modeling, though their immature nature currently …
emerged as a powerful tool for disease modeling, though their immature nature currently …
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham… - The Lancet, 2020 - thelancet.com
Background Cardiac muscle hypercontractility is a key pathophysiological abnormality in
hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow …
hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow …
Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven …
EE Nollet, I Duursma, A Rozenbaum… - European heart …, 2023 - academic.oup.com
Aims Genetic hypertrophic cardiomyopathy (HCM) is caused by mutations in sarcomere
protein-encoding genes (ie genotype-positive HCM). In an increasing number of patients …
protein-encoding genes (ie genotype-positive HCM). In an increasing number of patients …
Study design and rationale of EXPLORER-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy
Background: Obstructive hypertrophic cardiomyopathy (oHCM) is characterized by
unexplained left ventricular (LV) hypertrophy associated with dynamic LV outflow tract …
unexplained left ventricular (LV) hypertrophy associated with dynamic LV outflow tract …
Genetic restrictive cardiomyopathy: causes and consequences—an integrative approach
D Cimiotti, H Budde, R Hassoun, K Jaquet - International Journal of …, 2021 - mdpi.com
The sarcomere as the smallest contractile unit is prone to alterations in its functional,
structural and associated proteins. Sarcomeric dysfunction leads to heart failure or …
structural and associated proteins. Sarcomeric dysfunction leads to heart failure or …
Multi-omics profiling of hypertrophic cardiomyopathy reveals altered mechanisms in mitochondrial dynamics and excitation–contraction coupling
J Moore, J Ewoldt, G Venturini, AC Pereira… - International journal of …, 2023 - mdpi.com
Hypertrophic cardiomyopathy is one of the most common inherited cardiomyopathies and a
leading cause of sudden cardiac death in young adults. Despite profound insights into the …
leading cause of sudden cardiac death in young adults. Despite profound insights into the …
Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We
investigated the molecular basis of the cardiac phenotype in two mouse models at …
investigated the molecular basis of the cardiac phenotype in two mouse models at …
Advances in Hypertrophic Cardiomyopathy Disease Modelling Using hiPSC-Derived Cardiomyocytes
The advent of human induced pluripotent stem cells (hiPSCs) and their capacity to be
differentiated into beating human cardiomyocytes (CMs) in vitro has revolutionized human …
differentiated into beating human cardiomyocytes (CMs) in vitro has revolutionized human …
Critical evaluation of current hypotheses for the pathogenesis of hypertrophic cardiomyopathy
Hereditary hypertrophic cardiomyopathy (HCM), due to mutations in sarcomere proteins,
occurs in more than 1/500 individuals and is the leading cause of sudden cardiac death in …
occurs in more than 1/500 individuals and is the leading cause of sudden cardiac death in …